Listed SME IPO SPECIALITYMEDICINES

Speciality Medicines IPO GMP & Allotment

Speciality Medicines IPO is an SME public issue of a pharmaceutical company engaged in the marketing and distribution of specialty medicines, including high-cost drugs used for chronic and complex diseases. The IPO aims to raise funds primarily for business expansion and working capital needs. The issue opened on 20 March 2026 and is expected to raise around ₹29 crore, with a neutral grey market sentiment (GMP ~ ₹0) indicating cautious investor interest before listing. With growing demand for advanced healthcare treatments and specialty drugs, the company operates in a niche but expanding segment of the pharmaceutical industry, offering potential long-term growth opportunities.

IPO Price Band
₹117.00 - ₹124.00
Lot Size
1,000 Shares
Bidding Closes
24 Mar 2026
Listing Date
30 Mar 2026
Quick Answer & Highlights

Speciality Medicines IPO GMP Today & Key Takeaways

Last updated: 26 Mar 2026

Speciality Medicines IPO officially listed on 30 Mar 2026 at Rs 124.00, delivering a +0.00% listing gain compared to its issue price of Rs 124.00. Pre-listing, its final recorded Grey Market Premium (GMP) was ₹0.

Speciality Medicines IPO officially listed on 30 Mar 2026 at ₹124.00, delivering a +0.00% listing gain compared to its issue price of ₹124.00. Pre-listing, its final recorded Grey Market Premium (GMP) was ₹0.

Key Metric Figure Status / Context
Current GMP ₹0 +0% vs upper band (26 Mar 2026)
Est. Listing Price ₹124.00 +0.00% Est. Listing Gain
Price Band ₹117.00 - ₹124.00 SME IPO
Retail Minimum Investment ₹2,48,000 2 Lot (1,000 Shares)
Bidding Window 20 Mar 2026 – 24 Mar 2026 Listed
Allotment & Listing Dates Allotment: TBA Listing: 30 Mar 2026
Will you apply for this IPO?
Is this GMP accurate?
IPO Details

Complete IPO information

Speciality Medicines IPO Details and Specifications
IPO Open Date 20 Mar 2026
IPO Close Date 24 Mar 2026
IPO Price Band ₹117.00 - ₹124.00
Lot Size 1,000 Shares
Current GMP ₹0
Estimated Listing Gain +0.00%
Issue Size -
Fresh Issue -
Issue Type SME
IPO Listing NSE, BSE
Retail Quota TBA
Registrar TBA
Overall Subscription 2.27x
Minimum Investment ₹2,48,000
DRHP Draft Prospectus PDF
RHP Draft Prospectus -
Analysis

IPO Snapshot & Investor Takeaways

At the upper end of its price band, Speciality Medicines is priced at ₹124 per share. With a minimum lot size of 1,000 shares, a retail investor applying for one lot would need approximately ₹2,48,000 to participate in this SME issue.

The latest recorded Grey Market Premium for Speciality Medicines stands at ₹0, implying an estimated listing gain of around 0.00% over the issue price if it holds until listing. GMP reflects informal grey-market sentiment rather than a guaranteed outcome, and can change at any point until the day of listing.

As of the latest update, Speciality Medicines's IPO was subscribed 2.27x overall, with a category-wise breakdown of Retail 0.85x, QIB 96.24x.

SME IPOs list on the dedicated SME platform of BSE/NSE. They usually involve smaller issue sizes and a higher per-lot investment than Mainboard issues, with comparatively lower institutional participation.

Timeline

IPO roadmap at a glance

✓
Bidding Opens 20 Mar 2026
✓
Bidding Closes 24 Mar 2026
✓
Allotment TBA
✓
Listing 30 Mar 2026
Speciality Medicines IPO Timeline and Important Dates Schedule
Event / Milestone Scheduled Date Status
Bidding Opens 20 Mar 2026 Completed
Bidding Closes 24 Mar 2026 Completed
Allotment TBA Completed
Listing 30 Mar 2026 Completed
Grey Market Premium

Daily GMP status

Speciality Medicines IPO Daily Grey Market Premium (GMP) Trend & Price History
Date GMP Change Gain
26 Mar 2026 ₹0.00 - 0.00%
24 Mar 2026 ₹0.00 - 0.00%
23 Mar 2026 ₹0.00 - 0.00%
18 Mar 2026 ₹0.00 - 0.00%
Swipe to see more →
Market Lot

Application size breakdown

Speciality Medicines IPO Market Lot & Application Breakdown
Category Lots Shares Amount
Retail Minimum 2 Lot 2,000 ₹2,48,000
Retail Maximum 2 Lot 2,000 ₹2,48,000
S-HNI Minimum 3 Lot 3,000 ₹3,72,000
S-HNI Maximum 8 Lot 8,000 ₹9,92,000
B-HNI Minimum 9 Lot 9,000 ₹11,16,000
Swipe to see more →
Fund Utilization

Objects of the Issue & Official Documents

Analysis

IPO Reservation

Investor Category Shares Offered Shares (%)
Anchor Investor — Shares —%
QIB (Ex. Anchor) — Shares 2%
NII Shares Offered — Shares 49%
Retail Shares Offered — Shares 49%
Analysis

Speciality Medicines IPO Anchor Investors

Anchor Bidding Date 2026
Shares Offered — Shares
Anchor Size — Cr.
Lock-in Period (50% Shares - 30 Days) 2026
Lock-in Period (50% Shares - 90 Days) 2026
Analysis

Speciality Medicines IPO Dates

Particular Dates
IPO Open Date 20 Mar 2026
IPO Close Date 24 Mar 2026
Basis of Allotment -
Refunds -
Credit to Demat Account -
IPO Listing Date 30 Mar 2026

Note: The timeline for Speciality Medicines IPO is tentative and subject to change.

Analysis

Promoters and Holding Pattern

Promoters Parth B Goyani and Goyani Sumit Babubhai
Promoter Holding Pre Issue 64,35,796 Shares (59.28%)
Promoter Holding Post Issue 87,85,796 Shares (43.44%)
Analysis

Speciality Medicines Objects of the Issue & Utilisation of Proceeds

To Be Updated Soon

Analysis

Speciality Medicines Company Financials

To Be Updated Soon

Analysis

Speciality Medicines Company Valuation – FY2026

To Be Updated Soon

Analysis

Speciality Medicines IPO Peer Group Comparison

To Be Updated Soon

Analysis

IPO Lead Managers aka Merchant Bankers

  • Unicon Capital Services Pvt. Ltd. 
Comparison

Compare Speciality Medicines IPO with similar IPOs

FAQ

Speciality Medicines IPO FAQs

Speciality Medicines IPO GMP today is Rs 0. Investors can use this GMP along with price band and subscription status for a better IPO review.
Speciality Medicines IPO price band is Rs 117.00 to Rs 124.00. Check the latest issue price, lot size and GMP together before applying.
Speciality Medicines IPO open date is 20 Mar 2026, close date is 24 Mar 2026, and listing date is 30 Mar 2026.
Speciality Medicines IPO lot size is 1,000 shares. The minimum retail investment is Rs 2,48,000.
Speciality Medicines is classified as a SME IPO. This helps investors quickly understand the issue category and exchange segment.
Speciality Medicines IPO subscription status currently shows Retail 0.85x, QIB 96.24x, Overall 2.27x.
Speciality Medicines IPO is an SME public issue of a pharmaceutical company engaged in the marketing and distribution of specialty medicines, including high-cost drugs used for chronic and complex diseases. The IPO aims to raise funds primarily for business expansion and working capital needs. The issue opened on 20 March 2026 and is expected to raise around ₹29 crore, with a neutral grey market sentiment (GMP ~ ₹0) indicating cautious investor interest before listing. With growing demand for advanced healthcare treatments and specialty drugs, the company operates in a niche but expanding segment of the pharmaceutical industry, offering potential long-term growth opportunities.
In our empirical study of 117 Indian IPO listings, positive GMP was followed by a positive listing gain 69.8% of the time. However, as an exact forecast, the median variation between GMP-implied gain and actual listing price was 8 percentage points. GMP reflects informal market sentiment and should always be evaluated alongside company valuation and fundamentals.
Community discussion

Comments

Share a useful question or insight about Speciality Medicines.

Loading comments...

Leave a comment

Your email address will not be published. All comments and replies are reviewed before appearing.

Keep Exploring

Similar Recent IPOs

Related Topics
Speciality Medicines IPOSpeciality Medicines GMPSpeciality Medicines IPO GMPSpeciality Medicines IPO GMP todaySpeciality Medicines grey market premiumSpeciality Medicines price bandSpeciality Medicines subscription statusSpeciality Medicines allotment statusSpeciality Medicines listing dateSpeciality Medicines lot sizeSpeciality Medicines IPO reviewSpeciality Medicines IPO listing gain estimateSpeciality Medicines GMP calculatorSpeciality Medicines IPO 2026